Treace Medical Concepts, Inc. (TMCI) Dividend History

Treace Medical Concepts, Inc. (TMCI) is a medical device company specializing in innovative solutions for the treatment of foot and ankle conditions, particularly minimally invasive and reconstructive procedures. The company focuses on developing products that improve patient outcomes and surgical efficiency through advanced technology and design.

100 Palmetto Park Place, Ponte Vedra, FL, 32081
Phone: (904) 373-5940
Website: https://www.treace.com

Dividend History

Treace Medical Concepts, Inc. currently does not pay dividends

Company News

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating potential securities law violations by Treace Medical Concepts, Inc. (TMCI) and is encouraging affected investors to join the investigation.

Benzinga
DEADLINE ALERT for TMCI, IBTA, NPWR: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has filed class action lawsuits on behalf of shareholders of Treace Medical Concepts, Inc. (TMCI), Ibotta, Inc. (IBTA), and NET Power Inc. (NPWR) due to alleged securities fraud. Investors have until the specified deadlines to file as lead plaintiffs.

GlobeNewswire Inc.

Featured Companies: IBTA NPWR
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI

Levi & Korsinsky notifies investors in Treace Medical Concepts, Inc. (TMCI) of a class action securities lawsuit alleging the company made false statements and concealed information about declining demand for its primary product and the need to accelerate plans for an alternative product.

GlobeNewswire Inc.
Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Treace Medical Concepts, Inc. (TMCI) is facing a securities fraud lawsuit alleging that the company failed to disclose competition impacting the demand for its primary product, the Lapiplasty 3D Bunion Correction System, leading to a decline in revenue and the need to accelerate plans for an alternative product.

Benzinga
DEADLINE ALERT for CGC, TMCI, IBTA, NPWR: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Law Offices of Howard G. Smith has filed class action lawsuits against Canopy Growth Corporation, Treace Medical Concepts, Inc., Ibotta, Inc., and NET Power Inc. on behalf of shareholders, alleging securities fraud. Investors have until the specified deadlines to file as lead plaintiffs.

GlobeNewswire Inc.

Featured Companies: CGC IBTA NPWR

Dividend data last updated 06/07/2025 19:55:56 UTC